RxDoctor Payments Data

Amal Adely

Psychiatric/Mental Health · Greenwich, CTNPI 1447031695

Payments from drug & device makers

$2,926in general payments, 2019–2025

Across 119 payments — averaging $24.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$638
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$414
  • Alkermes, Inc.$367
  • Otsuka America Pharmaceutical, Inc.$259
  • Johnson & Johnson$236
  • Neurocrine Biosciences, Inc.$223
  • plus $790 from 15 others

What the payments were for

  • Food & beverage$2,926100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,926 in reported general payments places this provider in the 85th percentile of 679 psychiatric/mental health providers in Connecticut.

See all psychiatric/mental health providers in Connecticut

Medicare billing

Part B allowed, 2024
$15,681
Medicare patients
27
Services billed
146

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Desvenlafaxine Succinate ErDesvenlafaxine Succinate12$343
Lamotrigine20$262
Clonazepam26$261
Trazodone Hcl21$247
Aripiprazole12$161
Alprazolam15$139
Bupropion Hcl SrBupropion Hcl11$135
Fluoxetine Hcl30$103
Benztropine Mesylate11$82
Propranolol Hcl13$65
Ondansetron Hcl12$27

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Greenwich

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →